CoChat

Perforin Competent CD8 T Cells Are Sufficient to Cause Immune-Mediated Blood-Brain Barrier Disruption

Johnson, Holly L., Willenbring, Robin C., Jin, Fang, Manhart, Whitney A., LaFrance, Stephanie J., Pirko, Istvan, Johnson, Aaron J. · 2014 · PLoS ONE
Cited by 44

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0111401

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 44

  1. H Brown, 1999, Evidence of blood-brain barrier dysfunction in human cerebral malaria, Neuropathology and applied neurobiology, 25, 331, 10.1046/j.1365-2990.1999.00188.x · DOI · Paper page
  2. JD Huber, 2001, Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier, Trends in neurosciences, 24, 719, 10.1016/S0166-2236(00)02004-X · DOI · Paper page
  3. N Lacerda-Queiroz, 2012, Platelet-activating factor receptor is essential for the development of experimental cerebral malaria, The American journal of pathology, 180, 246, 10.1016/j.ajpath.2011.09.038 · DOI
  4. N Marchi, 2012, Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches, Epilepsia, 53, 1877, 10.1111/j.1528-1167.2012.03637.x · DOI · Paper page
  5. N Marchi, 2011, Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures, Epilepsia, 52, 1627, 10.1111/j.1528-1167.2011.03080.x · DOI
  6. IM Medana, 2006, Human cerebral malaria and the blood-brain barrier, International journal for parasitology, 36, 555, 10.1016/j.ijpara.2006.02.004 · DOI · Paper page
  7. A Minagar, 2003, Blood-brain barrier disruption in multiple sclerosis, Multiple sclerosis, 9, 540, 10.1191/1352458503ms965oa · DOI · Paper page
  8. I Pirko, 2008, Acute hemorrhagic demyelination in a murine model of multiple sclerosis, Journal of neuroinflammation, 5, 31, 10.1186/1742-2094-5-31 · DOI
  9. SW Schneider, 2004, Glioblastoma cells release factors that disrupt blood-brain barrier features, Acta Neuropathologica, 107, 272, 10.1007/s00401-003-0810-2 · DOI · Paper page
  10. D Talavera, 2004, IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers, The Journal of general virology, 85, 1801, 10.1099/vir.0.19652-0 · DOI · Paper page
  11. AJ Johnson, 2005, Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome, Journal of immunology, 174, 6854, 10.4049/jimmunol.174.11.6854 · DOI · Paper page
  12. J McDole, 2006, The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis, Neurological research, 28, 256, 10.1179/016164106X98125 · DOI · Paper page
  13. M Rodriguez, 1987, Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus, Critical reviews in immunology, 7, 325
  14. Johnson HL, Jin F, Pirko I, Johnson AJ (2013) Theiler's murine encephalomyelitis virus as an experimental model system to study the mechanism of blood-brain barrier disruption. Journal of neurovirology. · DOI
  15. AJ Johnson, 1999, Prevalent class I-restricted T-cell response to the Thelier's virus epitope D-b : VP2(121-130) in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28, Journal of Virology, 73, 3702, 10.1128/JVI.73.5.3702-3708.1999 · DOI · Paper page
  16. AJ Johnson, 2001, Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 15, 2760, 10.1096/fj.01-0373fje · DOI
  17. GL Suidan, 2008, Induction of blood brain barrier tight junction protein alterations by CD8 T cells, PloS one, 3, e3037, 10.1371/journal.pone.0003037 · DOI · Paper page
  18. D Janigro, 2012, Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood-brain barrier, Epilepsia, 53, 26, 10.1111/j.1528-1167.2012.03472.x · DOI · Paper page
  19. JF Bukowski, 1983, Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo, Journal of immunology, 131, 1531, 10.4049/jimmunol.131.3.1531 · DOI · Paper page
  20. CV Paya, 1989, Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus, Journal of immunology, 143, 95, 10.4049/jimmunol.143.1.95 · DOI
  21. T Wang, 2003, IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection, Journal of immunology, 171, 2524, 10.4049/jimmunol.171.5.2524 · DOI · Paper page
  22. DD Kish, 2012, Neutrophil expression of Fas ligand and perforin directs effector CD8 T cell infiltration into antigen-challenged skin, Journal of immunology, 189, 2191, 10.4049/jimmunol.1102729 · DOI
  23. GL Suidan, 2010, CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions, Journal of immunology, 184, 1031, 10.4049/jimmunol.0902773 · DOI · Paper page
  24. HL Johnson, 2012, CD8 T Cell-Initiated Blood-Brain Barrier Disruption Is Independent of Neutrophil Support, Journal of immunology, 189, 1937, 10.4049/jimmunol.1200658 · DOI
  25. A Denic, 2011, MRI in rodent models of brain disorders, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 8, 3, 10.1007/s13311-010-0002-4 · DOI
  26. I Pirko, 2004, Dynamics of MRI lesion development in an animal model of viral-induced acute progressive CNS demyelination, NeuroImage, 21, 576, 10.1016/j.neuroimage.2003.09.037 · DOI
  27. I Pirko, 2011, Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis, NeuroImage, 54, 802, 10.1016/j.neuroimage.2010.08.055 · DOI
  28. I Pirko, 2008, Multiple sclerosis: pathogenesis and MR imaging features of T1 hypointensities in a [corrected] murine model, Radiology, 246, 790, 10.1148/radiol.2463070338 · DOI
  29. RA Robb, 1999, 3-D visualization in biomedical applications, Annual review of biomedical engineering, 1, 377, 10.1146/annurev.bioeng.1.1.377 · DOI
  30. RA Robb, 2001, The Biomedical Imaging Resource at Mayo Clinic, Ieee Transactions on Medical Imaging, 20, 854, 10.1109/42.952724 · DOI · Paper page
  31. J Hao, 2010, Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology, The Journal of experimental medicine, 207, 1907, 10.1084/jem.20092749 · DOI · Paper page
  32. W Xu, 2005, Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis, Journal of neuroimmunology, 163, 24, 10.1016/j.jneuroim.2005.02.011 · DOI
  33. B Zhang, 1997, Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells, The Journal of experimental medicine, 186, 1677, 10.1084/jem.186.10.1677 · DOI · Paper page
  34. AJ Johnson, 1999, Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28, Journal of virology, 73, 3702, 10.1128/JVI.73.5.3702-3708.1999 · DOI · Paper page
  35. A Haque, 2011, Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria, Journal of immunology, 186, 6148, 10.4049/jimmunol.1003955 · DOI · Paper page
  36. J Tschopp, 1986, Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis, Nature, 322, 831, 10.1038/322831a0 · DOI · Paper page
  37. SE Stewart, 2014, The perforin pore facilitates the delivery of cationic cargos, The Journal of biological chemistry, 289, 9172, 10.1074/jbc.M113.544890 · doi:10.1074/jbc.m113.544890
  38. CJ Froelich, 1996, New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis, The Journal of biological chemistry, 271, 29073, 10.1074/jbc.271.46.29073 · DOI · Paper page
  39. SS Metkar, 2002, Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation, Immunity, 16, 417, 10.1016/S1074-7613(02)00286-8 · DOI · Paper page
  40. ME Pipkin, 2007, Delivering the kiss of death: progress on understanding how perforin works, Current opinion in immunology, 19, 301, 10.1016/j.coi.2007.04.011 · DOI · Paper page
  41. JE Knickelbein, 2008, Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency, Science, 322, 268, 10.1126/science.1164164 · DOI · Paper page
  42. Revelo XS, Tsai S, Lei H, Luck H, Ghazarian M, et al. (2014) Perforin is a Novel Immune Regulator of Obesity Related Insulin Resistance. Diabetes. · DOI · Paper page
  43. CE Terrell, 2013, Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells, Blood, 121, 5184, 10.1182/blood-2013-04-495309 · DOI · Paper page
  44. WJ Grossman, 2003, The orphan granzymes of humans and mice, Current opinion in immunology, 15, 544, 10.1016/S0952-7915(03)00099-2 · DOI

Cited by

See all 44

Metadata

Authors
Johnson, H. L., Willenbring, R. C., Jin, F., Manhart, W. A., LaFrance, S. J., Pirko, I., & Johnson, A. J.
Venue
PLoS ONE
Published
2014-10-22
Volume
9
Issue
10
Pages
e111401
ISSN
1932-6203
Cited by
44
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.